Zobrazeno 1 - 10
of 230
pro vyhledávání: '"Lori A. Goldstein"'
Autor:
Yuli Chen, Haojia Li, Andrew Janowczyk, Paula Toro, Germán Corredor, Jon Whitney, Cheng Lu, Can F. Koyuncu, Mojgan Mokhtari, Christina Buzzy, Shridar Ganesan, Michael D. Feldman, Pingfu Fu, Haley Corbin, Aparna Harbhajanka, Hannah Gilmore, Lori J. Goldstein, Nancy E. Davidson, Sangeeta Desai, Vani Parmar, Anant Madabhushi
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-10 (2023)
Abstract Prognostic markers currently utilized in clinical practice for estrogen receptor-positive (ER+) and lymph node-negative (LN−) invasive breast cancer (IBC) patients include the Nottingham grading system and Oncotype Dx (ODx). However, these
Externí odkaz:
https://doaj.org/article/67dd37d216ad4551903031aedcfbd8d7
Autor:
Haojia Li, Kaustav Bera, Paula Toro, PingFu Fu, Zelin Zhang, Cheng Lu, Michael Feldman, Shridar Ganesan, Lori J. Goldstein, Nancy E. Davidson, Akisha Glasgow, Aparna Harbhajanka, Hannah Gilmore, Anant Madabhushi
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-10 (2021)
Abstract Collagen fiber organization has been found to be implicated in breast cancer prognosis. In this study, we evaluated whether computerized features of Collagen Fiber Orientation Disorder in Tumor-associated Stroma (CFOD-TS) on Hematoxylin & Eo
Externí odkaz:
https://doaj.org/article/3f1567d71b5f43f1be83cf5666df32a7
Autor:
Lori J. Goldstein, Raymond P. Perez, Denise Yardley, Linda K. Han, James M. Reuben, Hui Gao, Susan McCanna, Beth Butler, Pier Adelchi Ruffini, Yi Liu, Roberto R. Rosato, Jenny C. Chang
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-9 (2020)
Abstract Background Cancer stem cells (CSCs) are purported to be responsible for tumor initiation, treatment resistance, disease recurrence, and metastasis. CXCR1, one of the receptors for CXCL8, was identified on breast cancer (BC) CSCs. Reparixin,
Externí odkaz:
https://doaj.org/article/ac829d2cdaf14d13a5d03603e1a74bd8
Autor:
Irene Kang, Jamie K. Forschmiedt, Michelle M. Loch, William E. Barlow, Danika L. Lew, Julie R. Gralow, Funda Meric-Bernstam, Kathy S. Albain, Daniel F. Hayes, Nancy U. Lin, Edith A. Perez, Lori J. Goldstein, Priya Rastogi, Anne F. Schott, Steven Shak, Priyanka Sharma, Jieling Miao, Debu Tripathy, Lajos Pusztai, Gabriel N. Hortobagyi, Kevin Kalinsky, N. Lynn Henry
Publikováno v:
Cancer Research. 83:GS1-04
Introduction: Breast cancer treatment is associated with cancer-related cognitive impairment (CRCI). However, the differential effect of endocrine therapy (ET) vs chemotherapy followed by endocrine therapy (CET), including the impact of menopausal st
Autor:
Kristen D. Whitaker, Xiaoliang Wang, Mustafa Ascha, Timothy N. Showalter, Heather G. Lewin, Gregory S. Calip, Lori J. Goldstein
Publikováno v:
Breast Cancer Research and Treatment. 196:163-173
Background Black women in the USA have a higher incidence and mortality of metastatic breast cancer (mBC) than White women, while Hispanic women have lower rates. Previous studies have focused on first-line (1L) treatment, but little is known about r
Autor:
William J. Gradishar, Meena S. Moran, Jame Abraham, Rebecca Aft, Doreen Agnese, Kimberly H. Allison, Bethany Anderson, Harold J. Burstein, Helen Chew, Chau Dang, Anthony D. Elias, Sharon H. Giordano, Matthew P. Goetz, Lori J. Goldstein, Sara A. Hurvitz, Steven J. Isakoff, Rachel C. Jankowitz, Sara H. Javid, Jairam Krishnamurthy, Marilyn Leitch, Janice Lyons, Joanne Mortimer, Sameer A. Patel, Lori J. Pierce, Laura H. Rosenberger, Hope S. Rugo, Amy Sitapati, Karen Lisa Smith, Mary Lou Smith, Hatem Soliman, Erica M. Stringer-Reasor, Melinda L. Telli, John H. Ward, Kari B. Wisinski, Jessica S. Young, Jennifer Burns, Rashmi Kumar
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:691-722
The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include recommendations for clinical management of patients with carcinoma in situ, inva
Autor:
Robert Gray, George W. Sledge, Nancy E. Davidson, Silvana Martino, Lawrence N. Shulman, Edith Perez, Steve Rowley, Roberto Bugarini, Frederick L. Baehner, Sunil Badve, Diana Brassard, Steven Shak, Barrett H. Childs, Lori J. Goldstein, Joseph A. Sparano
Supplementary Data from Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18650a49d46adff23b7ba64f40980162
https://doi.org/10.1158/1078-0432.22440490
https://doi.org/10.1158/1078-0432.22440490
Autor:
Robert Gray, George W. Sledge, Paraic A. Kenny, Nancy E. Davidson, Silvana Martino, Lawrence N. Shulman, Edith A. Perez, Steve Rowley, Roberto Bugarini, Frederick L. Baehner, Sunil Badve, Diana Brassard, Steven Shak, Barrett H. Childs, Lori J. Goldstein, Joseph A. Sparano
XLS file - 31K, Patient characteristics by GRB7 expression.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3aca49751437550bb5c121bed149fe42
https://doi.org/10.1158/1078-0432.22444047.v1
https://doi.org/10.1158/1078-0432.22444047.v1
Autor:
Robert Gray, George W. Sledge, Paraic A. Kenny, Nancy E. Davidson, Silvana Martino, Lawrence N. Shulman, Edith A. Perez, Steve Rowley, Roberto Bugarini, Frederick L. Baehner, Sunil Badve, Diana Brassard, Steven Shak, Barrett H. Childs, Lori J. Goldstein, Joseph A. Sparano
PDF file - 72K, Box plots (with center line at the median and box edges at the quartiles) showing the raw distribution of GRB7, ERBB2, KRT19 and PHB expression for the triple negative (TN) subset, hormone receptor negative (HR-), HER2-positive (HER2+
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cb2edb95da7855efadefd5624c45c08
https://doi.org/10.1158/1078-0432.22444050.v1
https://doi.org/10.1158/1078-0432.22444050.v1
Autor:
Max Wicha, Giraldo Kato, Raymond P. Perez, James M. Reuben, Susan McCanna, Pier Adelchi Ruffini, Massimo Cristofanilli, Lori J. Goldstein, Anne F. Schott
Table S1. Pharmacokinetic parameters of reparixin by cohort; Table S2. Pharmacokinetic parameters of paclitaxel; Table S3. Exploratory biomarkers.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bbd6ff8eb753424b07eb18294347bb0
https://doi.org/10.1158/1078-0432.22468131.v1
https://doi.org/10.1158/1078-0432.22468131.v1